CIK 0001072379 · Non-accelerated filer<br>Smaller reporting company
NORTHWEST BIOTHERAPEUTICS INC
Sign in to watch- Ticker
- NWBO
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943306718
- Phone
- (240) 497-9024
- Business address
- 4800 MONTGOMERY LANE, SUITE 800, BETHESDA, MD, 20814
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation
- 10-K/A Report 10-K/A
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 4 Open-market sale Director sold 570,000 shares at an average $0.82 ($469,430)
- 8-K Event Material agreement · New debt or obligation
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 4 Grant or award Chief Technical Officer acquired 119,355 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation
- 10-K Report Annual Report
Page 3 of 41 · 803 filings